Sunpeaks Ventures to Launch Clotamin Radio and Internet Advertising Campaign in Washington D.C.
SILVER SPRING, Md., May 3, 2012 /PRNewswire/ -- Sunpeaks Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS: SNPK) (the "Company" or "Sunpeaks Ventures") and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS") are pleased to announce that HDS has entered into an advertising agreement (the "Agreement") with Pulse Advertising LLC ("Pulse") for the marketing of Clotamin through a campaign of recorded radio commercials and premium online advertising. The Agreement is part of a new marketing initiative to promote the benefits of Clotamin in the Washington D.C. area.
Under terms of the Agreement, HDS has engaged Pulse to air a series of commercials on WTOP-FM and other Washington D.C. area affiliated stations for the marketing and promotion of Clotamin. The radio campaign is expected to run a total of 132 recorded 30-second Clotamin advertisements, including 92 guaranteed prime "drive time" plays and 40 additional plays (5am – midnight) to be aired over the 4 week duration of the contract period beginning May 15th, 2012. WTOP-FM is an all-news formatted radio station serving Metropolitan Washington, DC area. As of July 2009, WTOP has ranked #1 in the Arbitron ratings among radio stations in the Washington area and in 2010 received the National Association of Broadcasters Marconi Award for Major Market Station of the Year.
In conjunction with the radio ads, Pulse has also agreed to conduct an intensive online campaign featuring Clotamin on various internet properties. The one day blitz campaign, scheduled for May 16th, is expected to include Home Page Takeovers at WTOP.com. The online campaign is expected to produce up to 1,000,000 impressions/views.
"Washington D.C. is another key metropolitan area for potential Clotamin sales and the agreement with Pulse was designed to quickly enter this market by leveraging the promotional strengths of the all-news radio format with the persuasive reach of the internet," stated Mackie A. Barch, CEO of Sunpeaks Ventures. "We intend to continue to utilize both radio and the internet in other metropolitan areas to reach potential Clotamin users, their friends, and their families."
About Sunpeaks Ventures, Inc.
Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS"), is a nationally focused, value-added distributor of specialty drugs and over-the-counter ("OTC") branded multivitamins to the healthcare provider market. HDS also owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions.
For additional information, please visit www.sunpeaksventures.com.
Contact: Financial Insights 888-248-8491 or email@example.com
Safe Harbor Statement
Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "forecast", "anticipate", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Sunpeaks Ventures' actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in Sunpeaks Ventures' filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Sunpeaks Ventures herein are expressly qualified in their entirety by the above-mentioned cautionary statement. Sunpeaks Ventures disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.
SOURCE Sunpeaks Ventures, Inc.Back to top